These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10470557)

  • 1. Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.
    Andes DR; Craig WA
    Infect Dis Clin North Am; 1999 Sep; 13(3):595-618. PubMed ID: 10470557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis.
    Lutsar I; Friedland IR; Wubbel L; McCoig CC; Jafri HS; Ng W; Ghaffar F; McCracken GH
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2650-5. PubMed ID: 9756771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of antimicrobial therapy in surgery.
    DiPiro JT; Edmiston CE; Bohnen JM
    Am J Surg; 1996 Jun; 171(6):615-22. PubMed ID: 8678212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Ahmed A; Jafri H; Lutsar I; McCoig CC; Trujillo M; Wubbel L; Shelton S; McCracken GH
    Antimicrob Agents Chemother; 1999 Apr; 43(4):876-81. PubMed ID: 10103194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic pharmacodynamics in cerebrospinal fluid.
    Lutsar I; McCracken GH; Friedland IR
    Clin Infect Dis; 1998 Nov; 27(5):1117-27, quiz 1128-9. PubMed ID: 9827256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
    McCracken GH
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S45-50. PubMed ID: 10984328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of antibiotics in the therapy of meningitis: infection model observations.
    Schmidt T; Täuber MG
    J Antimicrob Chemother; 1993 May; 31 Suppl D():61-70. PubMed ID: 8335525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones.
    Dudley MN
    Am J Med; 1991 Dec; 91(6A):45S-50S. PubMed ID: 1767806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
    Roberts JA; Lipman J
    Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pharmacokinetics and pharmacodynamics: does the dose matter?
    MacGowan AP
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S238-9. PubMed ID: 11524725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New dosing strategies for antibacterial agents in the neonate.
    de Hoog M; Mouton JW; van den Anker JN
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):185-94. PubMed ID: 15701583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.
    Rodriguez-Cerrato V; McCoig CC; Michelow IC; Ghaffar F; Jafri HS; Hardy RD; Patel C; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3092-7. PubMed ID: 11600361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.
    Scheld WM
    Eur J Clin Microbiol; 1984 Dec; 3(6):579-91. PubMed ID: 6396094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.
    Sullins AK; Abdel-Rahman SM
    Paediatr Drugs; 2013 Apr; 15(2):93-117. PubMed ID: 23529866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolones in the Treatment of Meningitis.
    Cottagnoud P; Täuber MG
    Curr Infect Dis Rep; 2003 Aug; 5(4):329-336. PubMed ID: 12866985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolides: pharmacokinetics and pharmacodynamics.
    Van Bambeke F; Tulkens PM
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S17-23. PubMed ID: 11574190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis.
    McCoig CC; Wubbel L; Jafri HS; Lutsar I; Bastero R; Olsen K; Shelton S; Friedland IR; McCracken GH
    J Antimicrob Chemother; 1999 May; 43(5):683-8. PubMed ID: 10382890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion of beta-lactam antibiotics.
    MacGowan AP; Bowker KE
    Clin Pharmacokinet; 1998 Nov; 35(5):391-402. PubMed ID: 9839090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.